Acorda Therapeutics Price Prediction
| ACORDelisted Stock | USD 16.20 0.40 2.41% |
Oversold Vs Overbought
64
Oversold | Overbought |
Using Acorda Therapeutics hype-based prediction, you can estimate the value of Acorda Therapeutics from the perspective of Acorda Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Acorda Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Acorda because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Acorda Therapeutics after-hype prediction price | USD 16.2 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Acorda |
Acorda Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Acorda Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Acorda Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Acorda Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Acorda Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Acorda Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Acorda Therapeutics' historical news coverage. Acorda Therapeutics' after-hype downside and upside margins for the prediction period are 16.20 and 16.20, respectively. We have considered Acorda Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Acorda Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Acorda Therapeutics is based on 3 months time horizon.
Acorda Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Acorda Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Acorda Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Acorda Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 11 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
16.20 | 16.20 | 0.00 |
|
Acorda Therapeutics Hype Timeline
Acorda Therapeutics is presently traded for 16.20. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Acorda is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Acorda Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 16.20. About 13.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.05. Some equities with similar Price to Book (P/B) outperform the market in the long run. Acorda Therapeutics has Price/Earnings To Growth (PEG) ratio of 0.51. The entity recorded a loss per share of 203.57. The firm last dividend was issued on the 4th of January 2021. Acorda Therapeutics had 1:20 split on the 5th of June 2023. Given the investment horizon of 90 days the next estimated press release will be in 5 to 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.Acorda Therapeutics Related Hype Analysis
Having access to credible news sources related to Acorda Therapeutics' direct competition is more important than ever and may enhance your ability to predict Acorda Therapeutics' future price movements. Getting to know how Acorda Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Acorda Therapeutics may potentially react to the hype associated with one of its peers.
Acorda Therapeutics Additional Predictive Modules
Most predictive techniques to examine Acorda price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Acorda using various technical indicators. When you analyze Acorda charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Acorda Therapeutics Predictive Indicators
The successful prediction of Acorda Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Acorda Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Acorda Therapeutics based on analysis of Acorda Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Acorda Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Acorda Therapeutics's related companies.
Story Coverage note for Acorda Therapeutics
The number of cover stories for Acorda Therapeutics depends on current market conditions and Acorda Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Acorda Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Acorda Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Acorda Therapeutics Short Properties
Acorda Therapeutics' future price predictability will typically decrease when Acorda Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Acorda Therapeutics often depends not only on the future outlook of the potential Acorda Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acorda Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.2 M | |
| Cash And Short Term Investments | 30.4 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Acorda Stock
If you are still planning to invest in Acorda Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acorda Therapeutics' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |